XML 23 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Dec. 03, 2022
Nov. 27, 2021
Cash Flows from Operating Activities:    
Net earnings (loss) $ 44.9 $ (59.2)
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:    
Depreciation and amortization 77.7 109.9
Stock-based compensation 10.9 22.1
Amortization of deferred financing costs 2.3 1.4
Pension and post-retirement expenses (10.1) (4.2)
Deferred taxes (0.3) (13.6)
Restructuring expense 15.2 0.0
Impairment 0.0 15.5
Loss on extinguishment of debt 0.0 13.4
(Increase) decrease in current assets (34.7) (169.3)
(Decrease) increase in current liabilities (111.9) 34.9
(Decrease) increase in non-current liabilities (3.1) (5.3)
Other, net 3.8 (3.2)
Net Cash Used in Operating Activities (5.3) (57.6)
Cash Flows from Investing Activities:    
Notes receivables issued (4.5) 0.0
Capital expenditures (40.3) (46.3)
Acquisitions, net of cash received 0.0 (1,088.5)
Proceeds from loan on cash surrender value of life insurance 13.5 0.0
Other, net (0.7) 1.0
Net Cash Used in Investing Activities (32.0) (1,133.8)
Cash Flows from Financing Activities:    
Repayments of long-term debt (13.1) (50.0)
Proceeds from issuance of debt, net of discounts 0.0 1,007.0
Payments of deferred financing costs 0.0 (9.3)
Proceeds from credit facility 559.3 587.5
Repayments of credit facility (492.3) (449.4)
Payment of make whole premium on debt 0.0 (13.4)
Dividends paid (28.4) (25.4)
Common stock issued 2.5 4.3
Common stock repurchased and retired (14.3) (14.4)
Other, net (2.1) (1.4)
Net Cash Provided by Financing Activities 11.6 1,035.5
Effect of Exchange Rate Changes on Cash and Cash Equivalents (7.1) (13.2)
Net Decrease in Cash and Cash Equivalents (32.8) (169.1)
Cash and Cash Equivalents, Beginning of Period 230.3 396.4
Cash and Cash Equivalents, End of Period $ 197.5 $ 227.3